Key result
Doxorubicin drives cardiotoxicity via oxidative stress, necroptosis, mitochondrial impairment, and dysregulated apoptosis.
Why the study?
Despite its efficacy, doxorubicin's clinical significance is limited by cardiotoxicity, and the exact mechanism by which it induces cardiotoxicity remains an area of ongoing interest.
This review provides a summary of the molecular mechanisms driving doxorubicin-induced cardiotoxicity, emphasizing oxidative damage and cell death pathways.
No takes yet. Share an insight, caveat, or question.
Supports awareness of doxorubicin cardiotoxicity pathways; leaves open targeted cardioprotectants pending clinical validation.
Sangweni et al. (2022) conducted a review in Doxorubicin-induced cardiotoxicity. Doxorubicin was evaluated. Doxorubicin induces cardiotoxicity through multiple molecular mechanisms including oxidative stress, inflammatory cytokine-mediated necroptosis, impaired mitochondrial function, and dysregulated apoptosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: